4.7 Article

Moving beyond conventional stratified analysis to assess the treatment effect in a comparative oncology study

Related references

Note: Only part of the references are listed.
Article Oncology

ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer

Maria Gebre-Medhin et al.

Summary: The study demonstrates that for patients with locoregionally advanced HNSCC, cisplatin is superior to cetuximab in terms of locoregional control when used in combination with radiotherapy.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Medicine, General & Internal

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Statistics & Probability

Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study

Fei Jiang et al.

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2019)

Article Medicine, General & Internal

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer

L. Gandhi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Health Care Sciences & Services

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves

Patricia Guyot et al.

BMC MEDICAL RESEARCH METHODOLOGY (2012)

Article Mathematical & Computational Biology

Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: A principled yet flexible approach

Anastasios A. Tsiatis et al.

STATISTICS IN MEDICINE (2008)